Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle Fredman

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|June 26, 2015
Platelets: Context-Dependent Vascular Protectors or Mediators of DiseaseRandal Westrick, Gabrielle Fredman,
The American Journal of Pathology|May 22, 2017
Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for TherapyGabrielle Fredman, Ira Tabas
Cardiovascular Research|October 5, 2021
Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspectGabrielle Fredman, Katherine C MacNamara
Nature Reviews. Cardiology|January 12, 2024
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular diseaseGabrielle Fredman, Charles N Serhan
The Biochemical Journal|June 30, 2011
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolutionGabrielle Fredman, Charles N Serhan
Science Translational Medicine|June 6, 2014
Common therapeutic targets in cardiometabolic diseaseGabrielle Fredman, Lale Ozcan, Ira Tabas
Prostaglandins & Other Lipid Mediators|April 29, 2017
Pro-resolution therapeutics for cardiovascular diseasesJustin Heinz, Michael Marinello, Gabrielle Fredman
Frontiers in Immunology|June 28, 2021
Pro-Resolving Ligands Orchestrate PhagocytosisChrista Decker, Sudeshna Sadhu, Gabrielle Fredman
Current Opinion in Clinical Nutrition and Metabolic Care|December 17, 2016
Fine-tuning inflammation-resolution programs: focus on atherosclerosisGabrielle Fredman, Sudeshna Sadhu, Nicholas Rymut
Arteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2010
Resolvin E1 regulates adenosine diphosphate activation of human plateletsGabrielle Fredman, Thomas E Van Dyke, Charles N Serhan
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|June 26, 2015
Platelets: Context-Dependent Vascular Protectors or Mediators of DiseaseRandal Westrick, Gabrielle Fredman,
The American Journal of Pathology|May 22, 2017
Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for TherapyGabrielle Fredman, Ira Tabas
Cardiovascular Research|October 5, 2021
Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspectGabrielle Fredman, Katherine C MacNamara
Nature Reviews. Cardiology|January 12, 2024
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular diseaseGabrielle Fredman, Charles N Serhan
The Biochemical Journal|June 30, 2011
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolutionGabrielle Fredman, Charles N Serhan
Science Translational Medicine|June 6, 2014
Common therapeutic targets in cardiometabolic diseaseGabrielle Fredman, Lale Ozcan, Ira Tabas
Prostaglandins & Other Lipid Mediators|April 29, 2017
Pro-resolution therapeutics for cardiovascular diseasesJustin Heinz, Michael Marinello, Gabrielle Fredman
Frontiers in Immunology|June 28, 2021
Pro-Resolving Ligands Orchestrate PhagocytosisChrista Decker, Sudeshna Sadhu, Gabrielle Fredman
Current Opinion in Clinical Nutrition and Metabolic Care|December 17, 2016
Fine-tuning inflammation-resolution programs: focus on atherosclerosisGabrielle Fredman, Sudeshna Sadhu, Nicholas Rymut
Arteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2010
Resolvin E1 regulates adenosine diphosphate activation of human plateletsGabrielle Fredman, Thomas E Van Dyke, Charles N Serhan
Pageof 7